首页 > 最新文献

International journal of clinical and experimental medicine最新文献

英文 中文
Radial versus femoral artery access for percutaneous coronary angiography and intervention: a systematic review and meta-analysis of randomized controlled trials in Chinese population. 经皮冠状动脉造影和介入治疗的桡动脉与股动脉入路:中国人群随机对照试验的系统回顾和荟萃分析。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Peng Liu, Xue Liang Gao, Bei Fang Li, Xue Zhi Ding, Zi Hao Wang, Yan Ping Dang, Yang Gui Liu, Yun Fu Li

To compare the feasibility, efficiency and safety of coronary angiography (CAG) and interventional procedures between the radial and femoral catheterization approaches in Chinese population using systematic review and meta-analysis, we conducted a search of the studies comparing radial and femoral catheterization approaches in patients underwent either CAG or percutaneous coronary intervention (PCI) in Chinese population. Fixed-effect relative risk (RR) for the primary end points and the second end points were compared between the two approaches. A total of 27 studies (n=8,749 patients) were finally included in the analysis. The success rate of radial approach was slightly lower than that of femoral approach in patients receiving CAG (P=0.004), but similar in patients receiving a further PCI treatment (P=0.11). The risk of major adverse cardiovascular events (MACEs) was similar between two approaches (P=0.27). Radial catheterization had a significantly lower rate of puncture site complications (P<0.00001), but a lower rate of puncture success rate (P=0.02). In patients with acute myocardial infarction (AMI), there was no difference in neither the risk of MACEs nor PCI success rate between two approaches (P=0.23 and 0.45, respectively), but a board line decrease of puncture success rate was observed in radial catheterization group (P=0.04). There were no significant differences in the volumes of contrast media, X-ray exposure time and operation time between the two approaches (all P>0.05). Thus, we concluded that radial approach is a safe method for CAG or PCI compared to traditional femoral approach in Chinese population due to their similar success rate of the procedure and risk of MACEs, and a decreased risk of puncture site complications.

为了通过系统回顾和荟萃分析比较在中国人群中采用桡动脉和股动脉导管插入法进行冠状动脉造影(CAG)和介入手术的可行性、效率和安全性,我们检索了在中国人群中采用桡动脉和股动脉导管插入法对接受 CAG 或经皮冠状动脉介入治疗(PCI)的患者进行比较的研究。比较了两种方法的主要终点和次要终点的固定效应相对风险(RR)。最终共有 27 项研究(n=8749 名患者)被纳入分析。在接受CAG治疗的患者中,桡动脉入路的成功率略低于股动脉入路(P=0.004),但在接受进一步PCI治疗的患者中,桡动脉入路的成功率与股动脉入路相似(P=0.11)。两种方法发生主要不良心血管事件(MACE)的风险相似(P=0.27)。桡动脉导管术的穿刺部位并发症发生率明显较低(P0.05)。因此,我们得出结论,在中国人群中,桡动脉入路与传统的股动脉入路相比,是一种安全的 CAG 或 PCI 方法,因为两者的手术成功率和 MACE 风险相似,而穿刺部位并发症的风险较低。
{"title":"Radial versus femoral artery access for percutaneous coronary angiography and intervention: a systematic review and meta-analysis of randomized controlled trials in Chinese population.","authors":"Peng Liu, Xue Liang Gao, Bei Fang Li, Xue Zhi Ding, Zi Hao Wang, Yan Ping Dang, Yang Gui Liu, Yun Fu Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>To compare the feasibility, efficiency and safety of coronary angiography (CAG) and interventional procedures between the radial and femoral catheterization approaches in Chinese population using systematic review and meta-analysis, we conducted a search of the studies comparing radial and femoral catheterization approaches in patients underwent either CAG or percutaneous coronary intervention (PCI) in Chinese population. Fixed-effect relative risk (RR) for the primary end points and the second end points were compared between the two approaches. A total of 27 studies (n=8,749 patients) were finally included in the analysis. The success rate of radial approach was slightly lower than that of femoral approach in patients receiving CAG (P=0.004), but similar in patients receiving a further PCI treatment (P=0.11). The risk of major adverse cardiovascular events (MACEs) was similar between two approaches (P=0.27). Radial catheterization had a significantly lower rate of puncture site complications (P<0.00001), but a lower rate of puncture success rate (P=0.02). In patients with acute myocardial infarction (AMI), there was no difference in neither the risk of MACEs nor PCI success rate between two approaches (P=0.23 and 0.45, respectively), but a board line decrease of puncture success rate was observed in radial catheterization group (P=0.04). There were no significant differences in the volumes of contrast media, X-ray exposure time and operation time between the two approaches (all P>0.05). Thus, we concluded that radial approach is a safe method for CAG or PCI compared to traditional femoral approach in Chinese population due to their similar success rate of the procedure and risk of MACEs, and a decreased risk of puncture site complications. </p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"17151-66"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694209/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140193700","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma. 在存在胰岛素抵抗的情况下,不存在非酒精性脂肪肝是预测结直肠癌的一个强有力的指标。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Sebahat Basyigit, Metin Uzman, Ayse Kefeli, Ferdane Pirincci Sapmaz, Abdullah Ozgür Yeniova, Yasar Nazligul, Zeliha Asiltürk

Background: Colorectal carcinoma (CRC) and non-alcoholic fatty liver disease (NAFLD) share common risk factors. Insulin resistance (IR) has an important role in both diseases. It has been speculated that the prevalence of colorectal neoplasms might be increased in patients with NAFLD. However, It is unclear whether NAFLD is an actual risk factor or any association is incidental coexistance due to the role of IR in both disease. We aimed to assess the risk for CRC in patients with NAFLD in relation to IR.

Method: This study was designed prospectively and cross-sectionally. We determined NAFLD by ultrasonography and measured IR by the homeostatic model of assessment-insulin resistance model.

Results: The prevalences of CRC and adenoma were shown to be significantly higher in patients with IR (respectively; P: 0.005, P: 0.008). But prevalence of CRC was found to be significantly lower in subjects with NAFLD (P: 0.001). On multivariate logistic regression analysis, the risks of colorectal adenoma and carcinoma were significantly associated with the presence of IR (respectively; OR: 2.338, 95% CI: 1.080-4.993, P: 0.003 and : 5.023, 95% CI: 1.789-9.789, P: 0.001). The risk for CRC was significantly associated with the absence of NAFLD (OR: 7.380, 95% CI: 3.069-7.961, P: 0.010). The absence of NAFLD in the presence of IR was associated with significantly high risk for CRC (OR: 5.218, 95% CI: 1.538-7.448, P: 0.017).

Conclusion: The risk of CRC can increased in subjects with IR but without NAFLD. The absence of NAFLD in the presence of IR may predict the CRC.

背景:结直肠癌(CRC)和非酒精性脂肪肝(NAFLD)具有共同的风险因素。胰岛素抵抗(IR)在这两种疾病中都起着重要作用。据推测,非酒精性脂肪肝患者的结直肠肿瘤发病率可能会增加。然而,目前还不清楚非酒精性脂肪肝是否是一个真正的风险因素,或者说,由于 IR 在这两种疾病中的作用,任何关联都是偶然共存的。我们的目的是评估非酒精性脂肪肝患者罹患乳腺癌的风险与红外热的关系:本研究采用前瞻性横断面设计。我们通过超声波检查确定了非酒精性脂肪肝,并通过同态评估模型-胰岛素抵抗模型测量了IR:结果表明,IR 患者的 CRC 和腺瘤患病率明显更高(分别为:P: 0.005、P: 0.008)。但非酒精性脂肪肝患者的 CRC 患病率明显较低(P:0.001)。在多变量逻辑回归分析中,结直肠腺瘤和癌变的风险与 IR 的存在显著相关(分别为 OR:2.338,95% CI:1.080-4.993,P:0.003 和:5.023,95% CI:1.789-9.789,P:0.001)。罹患癌症的风险与是否患有非酒精性脂肪肝明显相关(OR:7.380,95% CI:3.069-7.961,P:0.010)。结论:没有非酒精性脂肪肝但存在 IR 的人患 CRC 的风险明显较高(OR:5.218,95% CI:1.538-7.448,P:0.017):结论:有 IR 但无 NAFLD 的受试者患 CRC 的风险会增加。结论:有 IR 但无 NAFLD 的受试者患 CRC 的风险会增加。
{"title":"Absence of non-alcoholic fatty liver disease in the presence of insulin resistance is a strong predictor for colorectal carcinoma.","authors":"Sebahat Basyigit, Metin Uzman, Ayse Kefeli, Ferdane Pirincci Sapmaz, Abdullah Ozgür Yeniova, Yasar Nazligul, Zeliha Asiltürk","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Colorectal carcinoma (CRC) and non-alcoholic fatty liver disease (NAFLD) share common risk factors. Insulin resistance (IR) has an important role in both diseases. It has been speculated that the prevalence of colorectal neoplasms might be increased in patients with NAFLD. However, It is unclear whether NAFLD is an actual risk factor or any association is incidental coexistance due to the role of IR in both disease. We aimed to assess the risk for CRC in patients with NAFLD in relation to IR.</p><p><strong>Method: </strong>This study was designed prospectively and cross-sectionally. We determined NAFLD by ultrasonography and measured IR by the homeostatic model of assessment-insulin resistance model.</p><p><strong>Results: </strong>The prevalences of CRC and adenoma were shown to be significantly higher in patients with IR (respectively; P: 0.005, P: 0.008). But prevalence of CRC was found to be significantly lower in subjects with NAFLD (P: 0.001). On multivariate logistic regression analysis, the risks of colorectal adenoma and carcinoma were significantly associated with the presence of IR (respectively; OR: 2.338, 95% CI: 1.080-4.993, P: 0.003 and : 5.023, 95% CI: 1.789-9.789, P: 0.001). The risk for CRC was significantly associated with the absence of NAFLD (OR: 7.380, 95% CI: 3.069-7.961, P: 0.010). The absence of NAFLD in the presence of IR was associated with significantly high risk for CRC (OR: 5.218, 95% CI: 1.538-7.448, P: 0.017).</p><p><strong>Conclusion: </strong>The risk of CRC can increased in subjects with IR but without NAFLD. The absence of NAFLD in the presence of IR may predict the CRC.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"18601-10"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694373/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141083091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects. 联合治疗对高血压患者动态血压的给药时间依赖性影响。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Weizhong Huangfu, Peilin Duan, Dingcheng Xiang, Ruiying Gao

The aim of this study was to explore the influence of combination therapy in different administration time on antihypertensive efficacy and blood pressure variability in patients with essential hypertension. A total of 86 patients with stage II to III essential hypertension were randomly divided into 4 groups: taking indapamide and losartan potassium together in the morning or in the evening 2 to 4 hours before sleep, indapamide in the morning and losartan potassium in the evening, losartan potassium in the morning and indapamide in the evening. Ambulatory blood pressure monitoring was performed before and 12 weeks after the medication. The result showed that statistically significant reductions from baseline of systolic blood pressure/diastolic blood pressure occurred in all treatment groups. There was no significant difference of the reductions or SI among the four groups, neither the rate of decline of BP in the night or the circadian rhythm. In group B, the numbers of rapid rise in BP in the morning hours were significantly less after the medication, while not in the other groups. It is concluded that independent of the administration time, both once-daily treatment and component-based dual therapy had significant antihypertensive effect, but the night taken-together combination resulted in reductions of BP, SI and morning blood pressure peak that may have advantages over the other combinations, without the increased incidence of hypotension at night. Medicines should be taken 2 to 4 hours before sleep.

本研究的目的是探讨不同给药时间的联合治疗对原发性高血压患者降压疗效和血压变异性的影响。将86例Ⅱ~Ⅲ期原发性高血压患者随机分为4组:在睡眠前2~4小时早晨或傍晚同时服用吲达帕胺和氯沙坦钾,早晨服用吲达帕胺,傍晚服用氯沙坦钾。用药前和用药后12周进行动态血压监测。结果显示,所有治疗组的收缩压/舒张压均较基线有统计学意义的降低。四组之间的血压下降率或SI、夜间血压下降率和昼夜节律均无显著差异。在B组中,用药后血压在早晨快速上升的次数显著减少,而在其他组中则没有。结论是,与给药时间无关,每日一次治疗和基于成分的双重治疗都具有显著的降压效果,但夜间联合用药可降低血压、SI和早晨血压峰值,与其他组合相比可能具有优势,而不会增加夜间低血压的发生率。药物应在睡觉前2-4小时服用。
{"title":"Administration time-dependent effects of combination therapy on ambulatory blood pressure in hypertensive subjects.","authors":"Weizhong Huangfu,&nbsp;Peilin Duan,&nbsp;Dingcheng Xiang,&nbsp;Ruiying Gao","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The aim of this study was to explore the influence of combination therapy in different administration time on antihypertensive efficacy and blood pressure variability in patients with essential hypertension. A total of 86 patients with stage II to III essential hypertension were randomly divided into 4 groups: taking indapamide and losartan potassium together in the morning or in the evening 2 to 4 hours before sleep, indapamide in the morning and losartan potassium in the evening, losartan potassium in the morning and indapamide in the evening. Ambulatory blood pressure monitoring was performed before and 12 weeks after the medication. The result showed that statistically significant reductions from baseline of systolic blood pressure/diastolic blood pressure occurred in all treatment groups. There was no significant difference of the reductions or SI among the four groups, neither the rate of decline of BP in the night or the circadian rhythm. In group B, the numbers of rapid rise in BP in the morning hours were significantly less after the medication, while not in the other groups. It is concluded that independent of the administration time, both once-daily treatment and component-based dual therapy had significant antihypertensive effect, but the night taken-together combination resulted in reductions of BP, SI and morning blood pressure peak that may have advantages over the other combinations, without the increased incidence of hypotension at night. Medicines should be taken 2 to 4 hours before sleep. </p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"19156-61"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694448/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71435109","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease. 冠心病急性心肌梗死和稳定型心绞痛阶段细胞因子表达的比较。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Wenwen Yan, Siwan Wen, Lemin Wang, Qianglin Duan, Lin Ding

Objective: To investigate the differential gene expression of cytokines and compare their impacts on the immune functions among the acute myocardial infarction patients (AMI), the stable angina patients (SA) and the controls.

Methods: 20 patients with AMI, 20 patients with SA and 20 healthy volunteers were recruited into the study. Whole human genome microarray analysis was used to detect the gene expression differences in interferons, interleukins, chemokines, tumor necrosis factors and associated receptors in peripheral blood mononuclear cells (PBMCs) among three groups.

Results: Compared with SA patients and the controls respectively, in AMI patients, IFNα2, IFNαR1, IFNαR2, IFNγR1, IFNγR2, L1β, IL16, IL18, Cxcl1, Cxcl2, Cxcl6, CxcR2, CxcR4, LIGHT, TNFR1, LT-βR, CD137, TRAILR, and TWEAKR mRNA expressions were significantly up-regulated (P<0.05), while Ccl5, Ccl24, Ccl28, CcR5, TWEAK, CD40, CD27, and BAFFR mRNA expressions were significantly down-regulated (P<0.05). But, there was no significant difference in cytokine expression between the SA patients and the controls.

Conclusion: In AMI patients, mRNA expression levels of cytokines were imbalanced, indicating the dysfunction of the immune system. Together with no significant change of cytokines was observed between the SA and controls, showing the different cytokine related immune activity in the AMI and SA patients.

目的研究急性心肌梗死(AMI)患者、稳定性心绞痛(SA)患者和对照组细胞因子基因表达的差异,并比较其对免疫功能的影响。采用全基因组芯片分析法检测三组患者外周血单核细胞(PBMCs)中干扰素、白细胞介素、趋化因子、肿瘤坏死因子及相关受体的基因表达差异:结果:与 SA 患者和对照组相比,AMI 患者的 IFNα2、IFNαR1、IFNαR2、IFNγR1、IFNγR2、L1β、IL16、IL18、Cxcl1、Cxcl2、Cxcl6、CxcR2、CxcR4、LIGHT、TNFR1、LT-βR、CD137、TRAILR 和 TWEAKR mRNA 表达明显上调(PConclusion:在 AMI 患者中,细胞因子 mRNA 表达水平失衡,表明免疫系统功能紊乱。此外,在 SA 和对照组之间未观察到细胞因子的明显变化,这表明 AMI 和 SA 患者与细胞因子相关的免疫活性不同。
{"title":"Comparison of cytokine expressions in acute myocardial infarction and stable angina stages of coronary artery disease.","authors":"Wenwen Yan, Siwan Wen, Lemin Wang, Qianglin Duan, Lin Ding","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the differential gene expression of cytokines and compare their impacts on the immune functions among the acute myocardial infarction patients (AMI), the stable angina patients (SA) and the controls.</p><p><strong>Methods: </strong>20 patients with AMI, 20 patients with SA and 20 healthy volunteers were recruited into the study. Whole human genome microarray analysis was used to detect the gene expression differences in interferons, interleukins, chemokines, tumor necrosis factors and associated receptors in peripheral blood mononuclear cells (PBMCs) among three groups.</p><p><strong>Results: </strong>Compared with SA patients and the controls respectively, in AMI patients, IFNα2, IFNαR1, IFNαR2, IFNγR1, IFNγR2, L1β, IL16, IL18, Cxcl1, Cxcl2, Cxcl6, CxcR2, CxcR4, LIGHT, TNFR1, LT-βR, CD137, TRAILR, and TWEAKR mRNA expressions were significantly up-regulated (P<0.05), while Ccl5, Ccl24, Ccl28, CcR5, TWEAK, CD40, CD27, and BAFFR mRNA expressions were significantly down-regulated (P<0.05). But, there was no significant difference in cytokine expression between the SA patients and the controls.</p><p><strong>Conclusion: </strong>In AMI patients, mRNA expression levels of cytokines were imbalanced, indicating the dysfunction of the immune system. Together with no significant change of cytokines was observed between the SA and controls, showing the different cytokine related immune activity in the AMI and SA patients.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"18082-9"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694304/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison between nitroglycerin and remifentanil in acute hypervolemic hemodilution combined with controlled hypotension during intracranial aneurysm surgery. 比较硝酸甘油和瑞芬太尼在颅内动脉瘤手术急性高血容量血液稀释合并控制性低血压中的作用。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Xuekang Zhang, Qian Hu, Zhiyi Liu, Haijin Huang, Qin Zhang, Hanying Dai

Allogenetic transfusion has long been considered to be a relatively safe and extremely effective blood transfusion treatment. However, acute hypervolemic hemodilution (AHH) combined with the remifentanil-induced controlled hypotension (CH) have rarely been examined. Herein, 40 intracranial aneurysm surgery patients were randomly divided into nitroglycerin group (A group, n=20) and remifentanil group (B group, n=20). During intracranial aneurysm surgery, MAP, HR, Hb, and Hct were recorded. SjvO2, PjvO2, SaO2, PaO2 were measured, and CaO2, Da-jvO2, CjvO2, CERO2, VADL were calculated. In addition, The venous blood samples were collected for determining PT, TT, APTT, FBG, VIII, VWF and electrolytes. The results show that HR in nitroglycerin group dramatically accelerated and HR in remifentanil group slowed at 30 minutes after hypotension and 5 minutes after aneurysm occlusion (P<0.01) after hypotension. Compared with A group, the SjvO2 and CjvO2 of B group increased significantly and the Da-jvO2 and CERO2 decreased significantly at T3, T4. In addition, There were no significant differences between after AHH and before AHH in two groups (P>0.05) on TT, PT, APTT, FIB, VIII, VWF, Na(+), Cl(-), K(+), Ca(2+). These results suggest that AHH combined with remifentanil-based CH significantly lowered cerebral metabolic rate of oxygen and had effects on blood coagulation without clinical hemorrhagic signs increased and had important clinical significance for blood conservation.

长期以来,异体输血一直被认为是一种相对安全且极为有效的输血治疗方法。然而,急性高血容量血液稀释(AHH)与瑞芬太尼诱导的控制性低血压(CH)联合应用的研究却很少。本文将 40 例颅内动脉瘤手术患者随机分为硝酸甘油组(A 组,20 例)和瑞芬太尼组(B 组,20 例)。在颅内动脉瘤手术过程中,记录 MAP、HR、Hb 和 Hct。测量 SjvO2、PjvO2、SaO2、PaO2,计算 CaO2、Da-jvO2、CjvO2、CERO2、VADL。此外,还采集了静脉血样本以测定 PT、TT、APTT、FBG、VIII、VWF 和电解质。结果显示,在低血压后 30 分钟和动脉瘤闭塞后 5 分钟(P0.05),硝酸甘油组心率急剧加快,而瑞芬太尼组心率减慢(P0.05),TT、PT、APTT、FIB、VIII、VWF、Na(+)、Cl(-)、K(+)、Ca(2+)均有明显变化。这些结果表明,AHH联合基于瑞芬太尼的CH可显著降低脑氧代谢率,并对血液凝固产生影响,而无临床出血征象增加,对血液保存具有重要的临床意义。
{"title":"Comparison between nitroglycerin and remifentanil in acute hypervolemic hemodilution combined with controlled hypotension during intracranial aneurysm surgery.","authors":"Xuekang Zhang, Qian Hu, Zhiyi Liu, Haijin Huang, Qin Zhang, Hanying Dai","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Allogenetic transfusion has long been considered to be a relatively safe and extremely effective blood transfusion treatment. However, acute hypervolemic hemodilution (AHH) combined with the remifentanil-induced controlled hypotension (CH) have rarely been examined. Herein, 40 intracranial aneurysm surgery patients were randomly divided into nitroglycerin group (A group, n=20) and remifentanil group (B group, n=20). During intracranial aneurysm surgery, MAP, HR, Hb, and Hct were recorded. SjvO2, PjvO2, SaO2, PaO2 were measured, and CaO2, Da-jvO2, CjvO2, CERO2, VADL were calculated. In addition, The venous blood samples were collected for determining PT, TT, APTT, FBG, VIII, VWF and electrolytes. The results show that HR in nitroglycerin group dramatically accelerated and HR in remifentanil group slowed at 30 minutes after hypotension and 5 minutes after aneurysm occlusion (P<0.01) after hypotension. Compared with A group, the SjvO2 and CjvO2 of B group increased significantly and the Da-jvO2 and CERO2 decreased significantly at T3, T4. In addition, There were no significant differences between after AHH and before AHH in two groups (P>0.05) on TT, PT, APTT, FIB, VIII, VWF, Na(+), Cl(-), K(+), Ca(2+). These results suggest that AHH combined with remifentanil-based CH significantly lowered cerebral metabolic rate of oxygen and had effects on blood coagulation without clinical hemorrhagic signs increased and had important clinical significance for blood conservation. </p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"19353-9"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694475/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081263","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Postmortem redistribution of lidocaine after epidural injection in beagle dogs. 小猎犬硬膜外注射利多卡因后的尸检再分布。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Chao Zhang, Bin Liang, Chendan Wang, Zhiwen Wei, Keming Yun

Objectives: An animal model using beagle dog has been established to investigate the postmortem redistribution of lidocaine.

Materials and methods: 18 dogs were euthanized and injected lidocaine (13 mg/kg) via epidural immediately. An autopsy was performed at 0, 12, 24, 48, 72, 96 hours after drug administration. All animals were stored in supine position at room temperature. For the other groups, lidocaine was given via epidural 6, 12, 24 hours after dogs were euthanized. Followed treatments were as above described. All samples were treated for detection of the concentration of lidocaine.

Results: It was found that lidocaine could diffuse via blood vessel rapidly post administration. And the concentration of lidocaine in the blood from ventriculus sinister increased obviously in a time-dependent manner. Meanwhile, the postmortem tissue distribution of lidocaine was significantly different. However, the process of postmortem redistribution of lidocaine was obviously delayed in dogs which were given drugs after death.

Conclusions: Together results revealed the process of postmortem redistribution of lidocaine via epidural injection, and provided the method to distinguish the lidocaine-induced death and drug administration after death.

材料和方法材料与方法:18 只狗被安乐术后,立即经硬膜外注射利多卡因(13 毫克/千克)。在给药后 0、12、24、48、72 和 96 小时进行尸检。所有动物均在室温下仰卧保存。其他组的动物在安乐死后 6、12、24 小时通过硬膜外注射利多卡因。后续处理如上所述。所有样本均用于检测利多卡因的浓度:结果:研究发现,利多卡因可在给药后迅速通过血管扩散。结果发现,利多卡因在给药后可通过血管迅速扩散,且静脉血中利多卡因的浓度呈明显的时间依赖性增加。同时,利多卡因在死后组织中的分布也有显著差异。然而,死后给药的狗体内利多卡因的死后再分布过程明显延迟:以上结果揭示了硬膜外注射利多卡因的死后再分布过程,为区分利多卡因致死和死后给药提供了方法。
{"title":"Postmortem redistribution of lidocaine after epidural injection in beagle dogs.","authors":"Chao Zhang, Bin Liang, Chendan Wang, Zhiwen Wei, Keming Yun","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objectives: </strong>An animal model using beagle dog has been established to investigate the postmortem redistribution of lidocaine.</p><p><strong>Materials and methods: </strong>18 dogs were euthanized and injected lidocaine (13 mg/kg) via epidural immediately. An autopsy was performed at 0, 12, 24, 48, 72, 96 hours after drug administration. All animals were stored in supine position at room temperature. For the other groups, lidocaine was given via epidural 6, 12, 24 hours after dogs were euthanized. Followed treatments were as above described. All samples were treated for detection of the concentration of lidocaine.</p><p><strong>Results: </strong>It was found that lidocaine could diffuse via blood vessel rapidly post administration. And the concentration of lidocaine in the blood from ventriculus sinister increased obviously in a time-dependent manner. Meanwhile, the postmortem tissue distribution of lidocaine was significantly different. However, the process of postmortem redistribution of lidocaine was obviously delayed in dogs which were given drugs after death.</p><p><strong>Conclusions: </strong>Together results revealed the process of postmortem redistribution of lidocaine via epidural injection, and provided the method to distinguish the lidocaine-induced death and drug administration after death.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"18500-5"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694359/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081269","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficiency of muscle strength training on motor function in patients with coronary artery disease: a meta-analysis. 肌力训练对冠心病患者运动功能的影响:一项荟萃分析。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Yu-Jie Yang, Xiao-Hua He, Hai-Ying Guo, Xue-Qiang Wang, Yi Zhu

Background: Existing literature has shown that patients with coronary artery disease (CAD) can benefit greatly from the strength training; therefore, the strength training should play a more important role in cardiac rehabilitation. However, the medical community may still have conservation to apply the strength training owing to no comprehensive study so far to compare the effectiveness of the strength training to the other trainings, such as aerobic training.

Objective: To evaluate the effect of strength training on motor function in patients with CAD.

Methods: Published articles from the earliest date available to July 2015 were identified using electronic searches. Two reviewers selected independently relevant randomized controlled trials (RCTs) investigating exercise program with strength training versus control interventions (exercise without strength training, including aerobic training and no exercise group) for the treatment of CAD patients. We examined effects of exercise with strength training versus control interventions on peak oxygen uptake (VO2peak), duration of exercise test and muscle strength. Two reviewers extracted data independently.

Results: Twenty seven trials that represented 1151 participants passed the selection criteria and were evaluated for the effects of strength training in CAD patients. For improving VO2peak [SMD (95%CI) = 0.58 (0.11, 1.06)] and muscle strength [upper limb, SMD (95% CI) =0.44 (0.34, 0.55); lower limb, SMD (95% CI) =0.33 (0.16, 0.50)], exercise program with strength training were significantly more effective than one without it. But there is no significantly difference on duration of exercise test [SMD (95%CI) = 0.17 (-0.04, 0.39)] in strength training group than in control group.

Conclusions: We conclude strength training is effective in improving muscle strength and VO2peak, in CAD patients, when compared to patients with control group. Furthermore, our evaluations suggest that strength training does not compromise clinical trial completion or safety.

背景:现有文献表明,冠状动脉疾病(CAD)患者可从力量训练中获益良多,因此,力量训练应在心脏康复中发挥更重要的作用。然而,由于迄今为止还没有一项全面的研究来比较力量训练与其他训练(如有氧训练)的效果,医学界可能仍然对力量训练的应用持保留态度:评估力量训练对 CAD 患者运动功能的影响:通过电子检索确定了从最早可获得的日期到 2015 年 7 月发表的文章。两名审稿人独立选择了相关的随机对照试验(RCT),这些试验研究了治疗 CAD 患者的带力量训练的运动项目与对照干预(不带力量训练的运动,包括有氧训练和无运动组)。我们研究了有力量训练的运动与对照干预对峰值摄氧量(VO2peak)、运动测试持续时间和肌肉力量的影响。两名审稿人独立提取数据:代表 1151 名参与者的 27 项试验通过了筛选标准,并评估了力量训练对 CAD 患者的影响。对于提高 VO2peak [SMD (95%CI) = 0.58 (0.11, 1.06)]和肌肉力量[上肢,SMD (95% CI) =0.44 (0.34, 0.55);下肢,SMD (95% CI) =0.33 (0.16, 0.50)],有力量训练的运动项目明显比没有力量训练的有效。但与对照组相比,力量训练组的运动测试持续时间[SMD (95%CI) = 0.17 (-0.04, 0.39)]没有明显差异:我们得出结论:与对照组相比,力量训练能有效改善 CAD 患者的肌肉力量和 VO2 峰值。此外,我们的评估表明,力量训练不会影响临床试验的完成或安全性。
{"title":"Efficiency of muscle strength training on motor function in patients with coronary artery disease: a meta-analysis.","authors":"Yu-Jie Yang, Xiao-Hua He, Hai-Ying Guo, Xue-Qiang Wang, Yi Zhu","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Background: </strong>Existing literature has shown that patients with coronary artery disease (CAD) can benefit greatly from the strength training; therefore, the strength training should play a more important role in cardiac rehabilitation. However, the medical community may still have conservation to apply the strength training owing to no comprehensive study so far to compare the effectiveness of the strength training to the other trainings, such as aerobic training.</p><p><strong>Objective: </strong>To evaluate the effect of strength training on motor function in patients with CAD.</p><p><strong>Methods: </strong>Published articles from the earliest date available to July 2015 were identified using electronic searches. Two reviewers selected independently relevant randomized controlled trials (RCTs) investigating exercise program with strength training versus control interventions (exercise without strength training, including aerobic training and no exercise group) for the treatment of CAD patients. We examined effects of exercise with strength training versus control interventions on peak oxygen uptake (VO2peak), duration of exercise test and muscle strength. Two reviewers extracted data independently.</p><p><strong>Results: </strong>Twenty seven trials that represented 1151 participants passed the selection criteria and were evaluated for the effects of strength training in CAD patients. For improving VO2peak [SMD (95%CI) = 0.58 (0.11, 1.06)] and muscle strength [upper limb, SMD (95% CI) =0.44 (0.34, 0.55); lower limb, SMD (95% CI) =0.33 (0.16, 0.50)], exercise program with strength training were significantly more effective than one without it. But there is no significantly difference on duration of exercise test [SMD (95%CI) = 0.17 (-0.04, 0.39)] in strength training group than in control group.</p><p><strong>Conclusions: </strong>We conclude strength training is effective in improving muscle strength and VO2peak, in CAD patients, when compared to patients with control group. Furthermore, our evaluations suggest that strength training does not compromise clinical trial completion or safety.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"17536-50"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694245/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141081242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Age plays an important role in the relationship between smoking status and obesity risk: a large scale cross-sectional study of Chinese adults. 年龄在吸烟状况与肥胖风险之间的关系中扮演重要角色:一项针对中国成年人的大规模横断面研究。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Pu Su, Liu Hong, Hang Sun, Yi Fan Zhao, Liang Li

Objective: To study the role of age plays in the relationship between smoking status and obesity in both Chinese men and women.

Methods: From Chinese Physical and Psychological Database, participants were divided into non-smokers, current smokers, and former smokers. Body mass index (BMI), waist circumference (WC), fat percentage, fat mass, and fat free mass were measured. The mean, standard deviation and frequency of these indicators were calculated for each age bracket. One-way ANOVA and post-hoc test analyses were used to detect the difference among these three groups.

Results: In men, from 19 to 24 years old, BMI, WC and fat free mass of current smokers were higher than that of non-smokers (P<0.01). However, fat mass and fat percentage of current smokers were lower than that of non-smokers but higher than that of former smokers (P<0.01). From 25 to 34 years old, BMI and fat mass of former smokers were higher than non-smokers and current smokers (P<0.01). In addition, WC and fat free mass of non-smokers were lower than that of current smokers and former smokers (P<0.01). From 45 to older, BMI, WC, fat mass, fat free mass and fat percentage of former smokers were higher than that of current smokers (P<0.01). From 55 to older, BMI, WC, fat mass, fat free mass and fat percentage of current smokers were lower than that of non-smokers (P<0.01). In women, smoking status might not be significantly related to obesity (P>0.05).

Conclusion: For young men, smoking might have an effect on increasing fat free mass, BMI and WC, and decreasing fat mass and fat percentage. For middle and older men, smoking might have an effect on decreasing fat free mass, fat mass, BMI, WC, and fat percentage. Obesity risk should be paid more attention in smoking cessation programs for those former smokers.

目的:研究中国男性和女性的吸烟状况与肥胖之间的关系:研究年龄在中国男性和女性吸烟状况与肥胖关系中的作用:方法:从中国人生理和心理数据库中,将参与者分为非吸烟者、现吸烟者和曾吸烟者。测量体重指数(BMI)、腰围(WC)、脂肪率、脂肪量和无脂肪量。计算了每个年龄段这些指标的平均值、标准差和频率。采用单因素方差分析和事后检验分析来检测这三个组之间的差异:结果:在 19 至 24 岁的男性中,吸烟者的体重指数、腹围和无脂质量均高于不吸烟者(P0.05):结论:对于年轻男性而言,吸烟可能会增加无脂质量、体重指数和腹围,降低脂肪量和脂肪率。对于中老年男性,吸烟可能会降低无脂质量、脂肪量、体重指数、腹围和脂肪率。在戒烟计划中,应更加关注曾经吸烟者的肥胖风险。
{"title":"Age plays an important role in the relationship between smoking status and obesity risk: a large scale cross-sectional study of Chinese adults.","authors":"Pu Su, Liu Hong, Hang Sun, Yi Fan Zhao, Liang Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To study the role of age plays in the relationship between smoking status and obesity in both Chinese men and women.</p><p><strong>Methods: </strong>From Chinese Physical and Psychological Database, participants were divided into non-smokers, current smokers, and former smokers. Body mass index (BMI), waist circumference (WC), fat percentage, fat mass, and fat free mass were measured. The mean, standard deviation and frequency of these indicators were calculated for each age bracket. One-way ANOVA and post-hoc test analyses were used to detect the difference among these three groups.</p><p><strong>Results: </strong>In men, from 19 to 24 years old, BMI, WC and fat free mass of current smokers were higher than that of non-smokers (P<0.01). However, fat mass and fat percentage of current smokers were lower than that of non-smokers but higher than that of former smokers (P<0.01). From 25 to 34 years old, BMI and fat mass of former smokers were higher than non-smokers and current smokers (P<0.01). In addition, WC and fat free mass of non-smokers were lower than that of current smokers and former smokers (P<0.01). From 45 to older, BMI, WC, fat mass, fat free mass and fat percentage of former smokers were higher than that of current smokers (P<0.01). From 55 to older, BMI, WC, fat mass, fat free mass and fat percentage of current smokers were lower than that of non-smokers (P<0.01). In women, smoking status might not be significantly related to obesity (P>0.05).</p><p><strong>Conclusion: </strong>For young men, smoking might have an effect on increasing fat free mass, BMI and WC, and decreasing fat mass and fat percentage. For middle and older men, smoking might have an effect on decreasing fat free mass, fat mass, BMI, WC, and fat percentage. Obesity risk should be paid more attention in smoking cessation programs for those former smokers.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"18894-906"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140193697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Influence of cell printing on biological characters of chondrocytes. 细胞打印对软骨细胞生物学特性的影响。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 DOI: 10.1166/JBT.2016.1420
M. Qu, Xiaoyan. Gao, Yikang Hou, Congcong Shen, Yourong Xu, Ming-sheng Zhu, Hengjian Wang, Haisong Xu, G. Chai, Yan Zhang
OBJECTIVETo establish a two-dimensional biological printing technique of chondrocytes and compare the difference of related biological characters between printed chondrocytes and unprinted cells so as to control the cell transfer process and keep cell viability after printing.METHODSPrimary chondrocytes were obtained from human mature and fetal cartilage tissues and then were regularly sub-cultured to harvest cells at passage 2 (P2), which were adjusted to the single cell suspension at a density of 1×10(6)/mL. The experiment was divided into 2 groups: experimental group P2 chondrocytes were transferred by rapid prototype biological printer (driving voltage value 50 V, interval in x-axis 300 μm, interval in y-axis 1500 μm). Afterwards Live/Dead viability Kit and flow cytometry were respectively adopted to detect cell viability; CCK-8 Kit was adopted to detect cell proliferation viability; immunocytochemistry, immunofluorescence and RT-PCR was employed to identify related markers of chondrocytes; control group steps were the same as the printing group except that cell suspension received no printing.RESULTSFluorescence microscopy and flow cytometry analyses showed that there was no significant difference between experimental group and control group in terms of cell viability. After 7-day in vitro culture, control group exhibited higher O.D values than experimental group from 2nd day to 7th day but there was no distinct difference between these two groups (P>0.05). Inverted microscope observation demonstrated that the morphology of these two groups had no significant difference either. Similarly, Immunocytochemistry, immunofluorescence and RT-PCR assays also showed that there was no significant difference in the protein and gene expression of type II collagen and aggrecan between these two groups (P>0.05). Conclusion Cell printing has no distinctly negative effect on cell vitality, proliferation and phenotype of chondrocytes. Biological printing technique may provide a novel approach for realizing the oriented, quantificational and regular distribution of chondrocytes in a two-dimensional plane and lay the foundation for the construction of three-dimensional cell printing or even organ printing system.
目的建立软骨细胞二维生物打印技术,比较打印软骨细胞与未打印软骨细胞相关生物学特性的差异,从而控制打印后的细胞转移过程,保持细胞活力。方法从人成熟软骨组织和胎儿软骨组织中获得原代软骨细胞,定期传代至2代(P2)收获细胞,调整为密度为1×10(6)/mL的单细胞悬液。实验分为两组:实验组采用快速原型生物打印机移植P2软骨细胞(驱动电压值50 V, x轴间隔300 μm, y轴间隔1500 μm)。分别采用活/死活力试剂盒和流式细胞术检测细胞活力;采用CCK-8试剂盒检测细胞增殖活力;采用免疫细胞化学、免疫荧光和RT-PCR检测软骨细胞相关标志物;对照组的步骤与打印组相同,只是细胞悬液不进行打印。结果荧光显微镜和流式细胞术分析显示,实验组与对照组的细胞活力差异无统计学意义。体外培养7 d后,第2 ~ 7 d,对照组的od值高于试验组,但两组间差异无统计学意义(P < 0.05)。倒置显微镜观察显示,两组的形态学也无显著差异。同样,免疫细胞化学、免疫荧光和RT-PCR检测也显示,两组间II型胶原和聚集蛋白的蛋白和基因表达差异无统计学意义(P < 0.05)。结论细胞打印对软骨细胞的活力、增殖和表型无明显的负面影响。生物打印技术可为实现软骨细胞在二维平面上定向、定量和规则分布提供一种新途径,为构建三维细胞打印甚至器官打印系统奠定基础。
{"title":"Influence of cell printing on biological characters of chondrocytes.","authors":"M. Qu, Xiaoyan. Gao, Yikang Hou, Congcong Shen, Yourong Xu, Ming-sheng Zhu, Hengjian Wang, Haisong Xu, G. Chai, Yan Zhang","doi":"10.1166/JBT.2016.1420","DOIUrl":"https://doi.org/10.1166/JBT.2016.1420","url":null,"abstract":"OBJECTIVE\u0000To establish a two-dimensional biological printing technique of chondrocytes and compare the difference of related biological characters between printed chondrocytes and unprinted cells so as to control the cell transfer process and keep cell viability after printing.\u0000\u0000\u0000METHODS\u0000Primary chondrocytes were obtained from human mature and fetal cartilage tissues and then were regularly sub-cultured to harvest cells at passage 2 (P2), which were adjusted to the single cell suspension at a density of 1×10(6)/mL. The experiment was divided into 2 groups: experimental group P2 chondrocytes were transferred by rapid prototype biological printer (driving voltage value 50 V, interval in x-axis 300 μm, interval in y-axis 1500 μm). Afterwards Live/Dead viability Kit and flow cytometry were respectively adopted to detect cell viability; CCK-8 Kit was adopted to detect cell proliferation viability; immunocytochemistry, immunofluorescence and RT-PCR was employed to identify related markers of chondrocytes; control group steps were the same as the printing group except that cell suspension received no printing.\u0000\u0000\u0000RESULTS\u0000Fluorescence microscopy and flow cytometry analyses showed that there was no significant difference between experimental group and control group in terms of cell viability. After 7-day in vitro culture, control group exhibited higher O.D values than experimental group from 2nd day to 7th day but there was no distinct difference between these two groups (P>0.05). Inverted microscope observation demonstrated that the morphology of these two groups had no significant difference either. Similarly, Immunocytochemistry, immunofluorescence and RT-PCR assays also showed that there was no significant difference in the protein and gene expression of type II collagen and aggrecan between these two groups (P>0.05). Conclusion Cell printing has no distinctly negative effect on cell vitality, proliferation and phenotype of chondrocytes. Biological printing technique may provide a novel approach for realizing the oriented, quantificational and regular distribution of chondrocytes in a two-dimensional plane and lay the foundation for the construction of three-dimensional cell printing or even organ printing system.","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10 1","pages":"17471-9"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"64479747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies. 碘化钠交感蛋白与分化型甲状腺癌的关系:9 项研究的荟萃分析。
IF 0.1 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Pub Date : 2015-10-15 eCollection Date: 2015-01-01
Rui Zhang, Huanjun Wang, Junyu Zhao, Jinming Yao, Hongxia Shang, Huangao Zhu, Lin Liao, Jianjun Dong

Context: As many studies proved that sodium iodide symporter (NIS) plays a key role in radioactive iodide (RAI) therapy of thyroid cancer, however, a growing number of studies suggests that part of differentiated thyroid carcinomas (DTC) with overexpression of NIS are insensitive to RAI well.

Objective: The aim of this meta-analysis is to assess the expression of NIS in differentiated thyroid cancer, compared with normal thyroid tissue.

Data sources: PUBMED, Sinomed, CNKI, Wanfang and VIP were searched for relevant case-control studies up to now.

Study selection: Studies that concerning the qualitative expression NIS in DTC were included.

Data extraction: Working independently, authors used a standard form to extract data. For quality assessment, Newcastle-Ottawa Scale (NOS) were applied.

Data synthesis: Totally nine eligible studies included, involving 765 cases and 473 controls. The results revealed that the expression of NIS had a statistically increased in DTC, compared with controls (OddsRadio OR: 1.47, 95% CI: 1.12 to 1.94, Z=2.78, P=0.005). Since the existence of the significant heterogeneity, subgroup analysis and sensitivity analysis were performed and found that the heterogeneity came from the different criteria evaluate positive NIS expression (Liu 2008, Mu 2010) and the small simple size of the control group (Lin. J D2001). The heterogeneity disappeared or dropped to below 50% after remove these studies.

Conclusion: Our study shows that the expression of NIS is significantly increased in DTC, which could help explain the reason for individual with a poor response to RAI therapy. In other word, the reduced iodide uptake in thyroid cancer may not caused by the decreased expression of NIS, function of NIS protein or its post-transcriptional translocation might be the point.

背景:许多研究证明,碘化钠合酶(NIS)在甲状腺癌的放射性碘化物(RAI)治疗中起着关键作用,然而,越来越多的研究表明,部分NIS过度表达的分化型甲状腺癌(DTC)对RAI不敏感:本荟萃分析旨在评估与正常甲状腺组织相比,NIS在分化型甲状腺癌中的表达情况:数据来源:检索了PUBMED、Sinomed、CNKI、万方和VIP网站上截至目前的相关病例对照研究:数据提取:数据提取:作者独立工作,使用标准表格提取数据。质量评估:采用纽卡斯尔-渥太华量表(NOS):共纳入 9 项符合条件的研究,涉及 765 例病例和 473 例对照。结果显示,与对照组相比,NIS在DTC中的表达有统计学意义的增加(OddsRadio OR:1.47,95% CI:1.12~1.94,Z=2.78,P=0.005)。由于存在明显的异质性,研究人员进行了亚组分析和敏感性分析,发现异质性来自于对 NIS 阳性表达的不同评价标准(Liu,2008 年;Mu,2010 年)和对照组的简单规模较小(Lin. J D2001)。去除这些研究后,异质性消失或降至 50%以下:我们的研究表明,NIS的表达在DTC中明显增加,这有助于解释个体对RAI治疗反应不佳的原因。换句话说,甲状腺癌患者碘摄取减少可能并非由NIS表达减少引起,NIS蛋白的功能或其转录后转位可能才是问题的关键。
{"title":"Association between sodium iodide symporter and differentiated Thyroid cancer: a meta-analysis of 9 studies.","authors":"Rui Zhang, Huanjun Wang, Junyu Zhao, Jinming Yao, Hongxia Shang, Huangao Zhu, Lin Liao, Jianjun Dong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Context: </strong>As many studies proved that sodium iodide symporter (NIS) plays a key role in radioactive iodide (RAI) therapy of thyroid cancer, however, a growing number of studies suggests that part of differentiated thyroid carcinomas (DTC) with overexpression of NIS are insensitive to RAI well.</p><p><strong>Objective: </strong>The aim of this meta-analysis is to assess the expression of NIS in differentiated thyroid cancer, compared with normal thyroid tissue.</p><p><strong>Data sources: </strong>PUBMED, Sinomed, CNKI, Wanfang and VIP were searched for relevant case-control studies up to now.</p><p><strong>Study selection: </strong>Studies that concerning the qualitative expression NIS in DTC were included.</p><p><strong>Data extraction: </strong>Working independently, authors used a standard form to extract data. For quality assessment, Newcastle-Ottawa Scale (NOS) were applied.</p><p><strong>Data synthesis: </strong>Totally nine eligible studies included, involving 765 cases and 473 controls. The results revealed that the expression of NIS had a statistically increased in DTC, compared with controls (OddsRadio OR: 1.47, 95% CI: 1.12 to 1.94, Z=2.78, P=0.005). Since the existence of the significant heterogeneity, subgroup analysis and sensitivity analysis were performed and found that the heterogeneity came from the different criteria evaluate positive NIS expression (Liu 2008, Mu 2010) and the small simple size of the control group (Lin. J D2001). The heterogeneity disappeared or dropped to below 50% after remove these studies.</p><p><strong>Conclusion: </strong>Our study shows that the expression of NIS is significantly increased in DTC, which could help explain the reason for individual with a poor response to RAI therapy. In other word, the reduced iodide uptake in thyroid cancer may not caused by the decreased expression of NIS, function of NIS protein or its post-transcriptional translocation might be the point.</p>","PeriodicalId":13892,"journal":{"name":"International journal of clinical and experimental medicine","volume":"8 10","pages":"17986-94"},"PeriodicalIF":0.1,"publicationDate":"2015-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4694293/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140193698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
International journal of clinical and experimental medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1